FY2026 EPS Estimate for Keros Therapeutics Lifted by Analyst
Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) – Equities research analysts at Leerink Partnrs upped their FY2026 earnings per share (EPS) estimates for Keros Therapeutics in a note issued to investors on Thursday, February 27th. Leerink Partnrs analyst T. Smith now anticipates that the company will post earnings per share of ($4.66) for the year, […]
Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) – Equities research analysts at Leerink Partnrs upped their FY2026 earnings per share (EPS) estimates for Keros Therapeutics in a note issued to investors on Thursday, February 27th. Leerink Partnrs analyst T. Smith now anticipates that the company will post earnings per share of ($4.66) for the year, […]
